Ventana Medical Systems Inc Roche Tissue Diagnostics 1910 E Innovation Park Drivetucson Az 85755 Pma Numberp210001 Supplement Numbers005 Date Received04 28 2022 Decision Date05 20 2022 Product Code Qnh Advisory Committee Pathology Clinical Trialsnct02628067 Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Ventana Medical Systems Inc Roche Tissue Diagnostics 1910 E Innovation Park Drivetucson Az 85755 Pma Numberp210001 Supplement Numbers005 Date Received04 28 2022 Decision Date05 20 2022 Product Code Qnh Advisory Committee Pathology Clinical Trialsnct02628067 Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P210001S005 Ventana Medical Systems Inc (Roche Tissue Diagnostics)1910 E. Innovation Park Drivetucson, AZ 85755 PMA NumberP210001 Supplement NumberS005 Date Received04/28/2022 Decision Date05/20/2022 Product Code QNH  Advisory Committee Pathology Clinical TrialsNCT02628067 Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No	VENTANA MMR RxDx Panel	2022-05-20